Literature DB >> 23135718

Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis.

Shashi A Gujar1, Patricia M Mulrooney-Cousins, Tomasz I Michalak.   

Abstract

Exposure to multiple small doses of hepatitis B virus (HBV) is a frequent occurrence in high-risk groups, including close relatives of infected individuals, primary care givers, and intravenous drug users. It remains uncertain whether such repeated contact may culminate in a symptomatic infection coinciding with hepatitis in individuals not immunoprotected. In this study, we evaluated consequences of multiple exposures to small, liver-nonpathogenic amounts of infectious hepadnavirus in the woodchuck model of hepatitis B. Virus-naïve animals were intravenously injected with 6 weekly doses of 110 DNase digestion-protected virions of woodchuck hepatitis virus (WHV), injected again with 6 weekly 110-virion doses after 7.5 months, and then challenged or not with a liver-pathogenic dose of 1.1 × 10(6) virions of the same inoculum. The data revealed that two rounds of such repeated exposure did not result in serologically evident infection or hepatitis. However, a low-level WHV DNA-positive infection accompanied by a WHV-specific T cell response in the absence of antiviral antibody reactivity was established. The kinetics of the virus-specific and mitogen-induced (generalized) T cell responses and the inability to induce immunoprotection against challenge with a large, liver-pathogenic virus dose were closely comparable to those previously reported for occult infection initiated by a single liver-nonpathogenic dose of WHV. Thus, repeated exposures to small quantities of hepadnavirus induce molecularly evident but serologically silent infection that does not culminate in hepatitis or generate immune protection. The findings imply that the HBV-specific T cell response encountered in the absence of serological markers of infection likely reflects ongoing occult infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135718      PMCID: PMC3554046          DOI: 10.1128/JVI.01363-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Statements from the Taormina expert meeting on occult hepatitis B virus infection.

Authors:  Giovanni Raimondo; Jean-Pierre Allain; Maurizia R Brunetto; Marie-Annick Buendia; Ding-Shinn Chen; Massimo Colombo; Antonio Craxì; Francesco Donato; Carlo Ferrari; Giovanni B Gaeta; Wolfram H Gerlich; Massimo Levrero; Stephen Locarnini; Thomas Michalak; Mario U Mondelli; Jean-Michel Pawlotsky; Teresa Pollicino; Daniele Prati; Massimo Puoti; Didier Samuel; Daniel Shouval; Antonina Smedile; Giovanni Squadrito; Christian Trépo; Erica Villa; Hans Will; Alessandro R Zanetti; Fabien Zoulim
Journal:  J Hepatol       Date:  2008-07-31       Impact factor: 25.083

Review 2.  Occupational exposure of health care personnel to hepatitis B and hepatitis C: prevention and surveillance strategies.

Authors:  Taranisia MacCannell; Angela K Laramie; Ahmed Gomaa; Joseph F Perz
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

Review 3.  Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses.

Authors:  Angela Michelin; David K Henderson
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

4.  Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.

Authors:  Dominique Challine; Stéphane Chevaliez; Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2008-07-17       Impact factor: 22.682

5.  Prevalence of occult hepatitis B virus infection in a general adult population in Korea.

Authors:  Eun Young Song; Yeo Min Yun; Myoung Hee Park; Dong Hee Seo
Journal:  Intervirology       Date:  2009-04-25       Impact factor: 1.763

6.  Reactivation of hepatitis B.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.

Authors:  Yong Fang; Qing-Long Shang; Jian-Yu Liu; Di Li; Wei-Zhen Xu; Xu Teng; Hong-Wei Zhao; Li-Juan Fu; Feng-Min Zhang; Hong-Xi Gu
Journal:  J Infect       Date:  2009-03-29       Impact factor: 6.072

8.  Early infection termination affects number of CD8+ memory T cells and protective capacities in listeria monocytogenes-infected mice upon rechallenge.

Authors:  Kuo-En Tseng; Cheng-Yu Chung; Weng Siong H'ng; Shih-Lien Wang
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection.

Authors:  Shashi A Gujar; Tomasz I Michalak
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

10.  Complete but curtailed T-cell response to very low-affinity antigen.

Authors:  Dietmar Zehn; Sarah Y Lee; Michael J Bevan
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  8 in total

1.  Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.

Authors:  Theo Heller; Jens Martin Werner; Fareed Rahman; Eishiro Mizukoshi; Yuji Sobao; Ann Marie Gordon; Arlene Sheets; Averell H Sherker; Ellen Kessler; Kathleen S Bean; Steven K Herrine; M'lou Stevens; James Schmitt; Barbara Rehermann
Journal:  J Infect Dis       Date:  2013-06-24       Impact factor: 5.226

2.  Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Authors:  Yufeng Song; Xiang Wang; Hongbo Zhang; Xinying Tang; Min Li; Jufang Yao; Xia Jin; Hildegund C J Ertl; Dongming Zhou
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 3.  Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.

Authors:  Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

4.  Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma.

Authors:  R Chauhan; N D Churchill; P M Mulrooney-Cousins; T I Michalak
Journal:  Oncogenesis       Date:  2017-04-17       Impact factor: 7.485

Review 5.  Occult Hepatitis B Virus Infection: An Update.

Authors:  Carlo Saitta; Teresa Pollicino; Giovanni Raimondo
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

6.  Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B.

Authors:  Patricia M Mulrooney-Cousins; Ranjit Chauhan; Norma D Churchill; Tomasz I Michalak
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

7.  Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B.

Authors:  Tomasz I Michalak
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

8.  Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation.

Authors:  Naoki Yamamoto; Georg Bauer
Journal:  Med Hypotheses       Date:  2020-08-05       Impact factor: 1.538

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.